Innovative Solutions in Medical Research
Advancing Biopharmaceuticals to Improve Lives
About Regenerative Medicine of Europe
Our Story
Regenerative Medicine of Europe (RME) owns the rights to drug therapies that are in development to treat Parkinson's Disease, ALS, Stroke Recovery, Alzheimer’s Disease, MSA, Vascular Dementia, CTE, TBI, Diabetic Foot Ulcers, Venous Leg Ulcers, Coronary Artery Disease, Peripheral Artery Disease (PAD), and MS. Over $130 Million USD has been expended in advancing and developing these drugs.